Researchers at Arizona State University’s Biodesign Institute explores an innovative means of investigating membrane proteins produced by a pair of highly pathogenic organisms. The research team showed that DNA-based genetic immunization, using a device known as a gene gun, could successfully express membrane proteins in mice and induce the animals to produce a range of critical antibodies to bacterial and viral targets.
Author Archive: AZBio
The Vision of Precision Medicine Takes Another Leap Forward
To enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward development of individualized care. (Mission Statement of the White House Precision Medicine Initiative.)Continue reading
UA Senior Vice President for Health Sciences Dr. Joe G.N. ‘Skip’ Garcia Selected for American Thoracic Society’s Prestigious 2016 Trudeau Medal
The Society’s highest award recognizes lifelong major contributions to the prevention, diagnosis and treatment of lung disease through leadership in research, education and clinical care.Continue reading
Mayo Clinic Arizona cuts the ribbon on the Southwest’s First Proton Therapy Facility
Proton beam therapy expands Mayo Clinic’s cancer care capabilities. In properly selected patients — especially children and young adults and those with cancers located close to critical organs and body structures — proton beam therapy is an advance over traditional radiotherapy.Continue reading
AdvaMed Names Scott Whitaker CEO and President
Washington, DC (February 18, 2016) — The Board of Directors of the Advanced Medical Technology Association (AdvaMed) announced today that Scott Whitaker will be its next president and chief executive officer effective April 4, 2016.Continue reading
CANCER MOONSHOT 2020 ANNOUNCES THE FORMATION OF A NATIONAL PEDIATRICS CONSORTIUM, A MAJOR MILESTONE IN THE WAR ON CANCER IN CHILDREN
Leading national children’s hospitals, pediatric cancer organizations and academic centers unite with Cancer MoonShot 2020 to accelerate bringing the next-generation standard of cancer care and immunotherapy to children with cancer. The Cancer MoonShot 2020 Pediatrics Consortium include 10 founding members spanning major cities across the nation who will participate in a national data sharing infrastructure to accelerate clinical development of next-generation immunotherapyContinue reading
Why Contact Lens Wearers Benefit from Annual Eye Exams
Having good eyesight is a gift. When age or health issues affect our vision, life science innovations as prescribed by our healthcare professionals help us improve our vision and protect the health of our eyes.Continue reading
Insys Therapeutics Enrolls First Patient in Phase II Study for the Treatment of Infantile Spasms Using Pharmaceutical CBD
Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced that the Company has enrolled the first patient in a Phase II clinical study for the treatment of infantile spasms (IS) using its pharmaceutical CBD (CBD) product candidate.
UA College of Medicine – Phoenix Granted Provisional Accreditation
Approval is the next step to full accreditation for the medical school